144 related articles for article (PubMed ID: 9100079)
1. [In vitro antifungal activity of rilopirox, a new hydroxypyridone antimycotic agent].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1997 Feb; 50(2):195-9. PubMed ID: 9100079
[TBL] [Abstract][Full Text] [Related]
2. [The in vitro properties of a new hydroxypyridone antimycotic rilopirox, with special reference to its anti-Candida activity].
Harada I; Mitsui K; Uchida K; Yamaguchi H
Jpn J Antibiot; 1999 Feb; 52(2):146-52. PubMed ID: 10221179
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antifungal activity of omoconazole nitrate, a new imidazole antimycotic].
Itoyama T; Aoki Y; Hiratani T; Uchida K; Yamaguchi H
Jpn J Antibiot; 1993 Sep; 46(9):773-80. PubMed ID: 8254897
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Candida albicans adhesiveness to human buccal and vaginal cells by sub-inhibitory concentrations of rilopirox.
Braga PC; Dal Sasso M; Maci S; Piatti G; Dannhorn DR; Bohn M
Arzneimittelforschung; 1995 Jan; 45(1):84-7. PubMed ID: 7893277
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of rilopirox against fluconazole-susceptible and fluconazole-resistant Candida isolates from patients with HIV infection.
Nenoff P; Taneva E; Pfeil B; Oswald U; Haustein UF
Mycoses; 1999 Apr; 42(1-2):55-60. PubMed ID: 10394849
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility testing of Malassezia furfur against rilopirox.
Nenoff P; Haustein UF
Skin Pharmacol; 1997; 10(5-6):275-80. PubMed ID: 9449166
[TBL] [Abstract][Full Text] [Related]
7. Alterations in surface morphology of Candida albicans produced by rilopirox: a scanning electron microscopy study.
Braga PC; Maci S; Dal Sasso M; Piatti G; Bohn M
J Chemother; 1995 Dec; 7(6):519-24. PubMed ID: 8667036
[TBL] [Abstract][Full Text] [Related]
8. In vitro investigations on the mode of action of the hydroxypyridone antimycotics rilopirox and piroctone on Candida albicans.
Sigle HC; Schäfer-Korting M; Korting HC; Hube B; Niewerth M
Mycoses; 2006 May; 49(3):159-68. PubMed ID: 16681805
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro activity of ciclopirox olamine, butenafine HCl and econazole nitrate against dermatophytes, yeasts and bacteria.
Kokjohn K; Bradley M; Griffiths B; Ghannoum M
Int J Dermatol; 2003 Sep; 42 Suppl 1():11-7. PubMed ID: 12895182
[TBL] [Abstract][Full Text] [Related]
10. Rilopirox--a new hydroxypyridone antifungal with fungicidal properties.
Raether W; Hänel H
Mycoses; 1990 Apr; 33(4):191-202. PubMed ID: 2233892
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antifungal spectrum of ciclopiroxolamine].
Goudard M; Regli P; Lubrano N
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):621-3. PubMed ID: 2797886
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of three topical antimycotics against ring-worm fungi singly and in combination.
Rai MK; Upadhyay SK; Agrawal SC
Hindustan Antibiot Bull; 1992; 34(3-4):104-7. PubMed ID: 1289296
[TBL] [Abstract][Full Text] [Related]
13. Studies for the elucidation of the mode of action of the antimycotic hydroxypyridone compound, rilopirox.
Kruse R; Hengstenberg W; Hänel H; Raether W
Pharmacology; 1991; 43(5):247-55. PubMed ID: 1664523
[TBL] [Abstract][Full Text] [Related]
14. Oxygen accessibility and iron levels are critical factors for the antifungal action of ciclopirox against Candida albicans.
Sigle HC; Thewes S; Niewerth M; Korting HC; Schäfer-Korting M; Hube B
J Antimicrob Chemother; 2005 May; 55(5):663-73. PubMed ID: 15790671
[TBL] [Abstract][Full Text] [Related]
15. Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.
Carrillo-Muñoz AJ; Brió S; Alonso R; del Valle O; Santos P; Quindós G
Int J Antimicrob Agents; 2002 Nov; 20(5):375-9. PubMed ID: 12431873
[TBL] [Abstract][Full Text] [Related]
16. A clinical and laboratory study of ciclopirox olamine (8% Batrafen) in the treatment of onychomycosis.
Yu B; Zhou G; Wang B; Ben Y; Yan H; Shao Y; Wang B
Chin Med Sci J; 1991 Sep; 6(3):166-8. PubMed ID: 1838936
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antifungal activity of itraconazole: a comparative study with ketoconazole].
Hiratani T; Yamaguchi H
Jpn J Antibiot; 1991 May; 44(5):580-7. PubMed ID: 1652656
[TBL] [Abstract][Full Text] [Related]
18. [In vitro action spectrum of a new antifungal agent derived from morpholine: amorolfin].
Regli P; Ferrari H
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):617-20. PubMed ID: 2797885
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal activities of luliconazole, a new topical imidazole.
Koga H; Nanjoh Y; Makimura K; Tsuboi R
Med Mycol; 2009; 47(6):640-7. PubMed ID: 19115136
[TBL] [Abstract][Full Text] [Related]
20. [In vitro antifungal activity of amorolfine, a new morpholine antimycotic agent].
Hiratani T; Asagi Y; Matsusaka A; Uchida K; Yamaguchi H
Jpn J Antibiot; 1991 Sep; 44(9):993-1006. PubMed ID: 1960861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
